Nature Research

SHERPA: Unknown

People

  1. Reuter
    Reuter
  2. Ladanyi
    Ladanyi
  3. Klimstra
    Klimstra
  4. Al-Ahmadie
    Al-Ahmadie
  5. Fine
    Fine
  6. Tickoo
    Tickoo
  7. Gopalan
    Gopalan
  8. Antonescu
    Antonescu
  9. Shia
    Shia
  10. Chen
    Chen

Groups

  1. Department of Pathology and Laboratory Medicine (1457)
  2. GSK Faculty (537)
  3. Surgery (392)
  4. GDMT, Pathology and Laboratory Medicine (355)
  5. Gynecology Disease Management Team (355)
  6. Department of Medicine (344)
  7. Tow Center for Developmental Oncology (TCDO) (323)
  8. Human Oncology and Pathogenesis Program (312)
  9. Solid Tumor Oncology Division (265)
  10. Sloan Kettering Institute Postdocs (230)
Search Within
Formats
  1. Meeting Abstract (1494)
  2. Journal Article (347)
  3. Editorial (18)
  4. Review (16)
  5. Correspondence (2)
  6. Guidelines (1)
Groups
  1. Department of Pathology and Laboratory Medicine (1457)
  2. GSK Faculty (537)
  3. Surgery (392)
  4. GDMT, Pathology and Laboratory Medicine (355)
  5. Gynecology Disease Management Team (355)
  6. Department of Medicine (344)

More Groups

People
  1. Victor Reuter (256)
  2. David Klimstra (218)
  3. Robert Soslow (197)
  4. Marc Ladanyi (191)
  5. Hikmat Al-Ahmadie (164)
  6. Samson Fine (159)

More People

Years
  1. 2025 (15)
  2. 2024 (28)
  3. 2023 (32)
  4. 2022 (118)
  5. 2021 (93)
  6. 2020 (64)

More Years

Publications
  1. Modern Pathology (1812)
  2. Nature Cancer (66)

Results (1878)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Toward deploying a deep learning model for diagnosis of rhabdomyosarcoma
    Correspondence

    Ho, D. J.; Agaram, N. P.; Frankel, A. O.; Lathara, M.; Catchpoole, D.; Keller, C.; Hameed, M. R.
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Nonlobular invasive breast carcinomas with biallelic pathogenic CDH1 somatic alterations: A histologic, immunophenotypic, and genomic characterization
    Journal Article

    Derakhshan, F.; Da Cruz Paula, A.; Selenica, P.; da Silva, E. M.; Grabenstetter, A.; Jalali, S.; Gazzo, A. M.; Dopeso, H.; Marra, A.; Brown, D. N.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Sarcomas with RAD51B fusions are associated with a heterogeneous phenotype
    Journal Article

    Chang, H. Y.; Dermawan, J.; Sharma, A.; Dickson, B.; Turashvili, G.; Torrence, D.; Nucci, M.; Chiang, S.; Oliva, E.; Kirchner, M.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma
    Journal Article

    Rialdi, A.; Duffy, M.; Scopton, A. P.; Fonseca, F.; Zhao, J. N.; Schwarz, M.; Molina-Sanchez, P.; Mzoughi, S.; Arceci, E.; Abril-Fornaguera, J.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia
    Journal Article

    Knorr, K.; Rahman, J.; Erickson, C.; Wang, E.; Monetti, M.; Li, Z.; Ortiz-Pacheco, J.; Jones, A.; Lu, S. X.; Stanley, R. F.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
    Journal Article

    Maura, F.; Boyle, E. M.; Coffey, D.; Maclachlan, K.; Gagler, D.; Diamond, B.; Ghamlouch, H.; Blaney, P.; Ziccheddu, B.; Cirrincione, A.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • HER2 genetic intratumor heterogeneity is associated with resistance to trastuzumab and trastuzumab emtansine therapy in recurrent high-grade endometrial cancer
    Journal Article

    Shen, S.; Ma, W.; Brown, D.; Da Cruz Paula, A.; Zhou, Q.; Iaosonos, A.; Tessier-Cloutier, B.; Ross, D. S.; Troso-Sandoval, T.; Reis-Filho, J. S.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Filippo Giancotti (1958-2023)
    Editorial

    DePinho, R.; Massagué, J.; Manji, G.; Rustgi, A. K.; Izar, B.
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Vepafestinib: a RET-selective inhibitor with enhanced CNS penetrance targets therapy-resistant mutants
    Editorial

    Odintsov, I.; Somwar, R.
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Comprehensive molecular characterization of polymorphous adenocarcinoma, cribriform subtype: Identifying novel fusions and fusion partners
    Journal Article

    Hahn, E.; Xu, B.; Katabi, N.; Dogan, S.; Smith, S. M.; Perez-Ordonez, B.; Patel, P. B.; Macmillan, C.; Lubin, D. J.; Gagan, J.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save

    • Nature Research – authorized name for: